Literature DB >> 10849311

New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus.

T Hasebe1, K Mukai, H Tsuda, A Ochiai.   

Abstract

Immunohistochemistry, DNA ploidy analysis and molecular genetics have made it possible to predict the outcome of breast cancer more precisely than routine histological examination alone. However, in routine practice, it is difficult to incorporate these methodologies in all cases. If certain histological parameters can accurately predict the outcome of patients with breast cancer, they would be more practical for routine use. We showed that the presence of fibrotic focus (FF) in invasive ductal carcinoma (IDC) is closely associated with c-erbB-2 or p53 protein expression, high proliferative activity, and high angiogenesis of the tumors. Furthermore, multivariate analyses with well-known prognostic parameters for IDC demonstrated that the presence of FF is the most useful independent parameter to predict IDC patient outcome. In addition, our data suggested that the interaction between tumor cells and stromal fibroblasts may play an important role in the formation of FF in IDC based on growth factor and growth factor receptor protein expression in the tumor cells and fibroblasts forming FF. Based on the results of our clinicopathological studies, we propose a new prognostic classification scheme for the prediction of IDC patient outcome, which consists of FF, nuclear atypia, and fat invasion. This classification has superior predicting power to existing prognostic classifications.

Entities:  

Mesh:

Year:  2000        PMID: 10849311     DOI: 10.1046/j.1440-1827.2000.01035.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  19 in total

1.  Adaptive clutter rejection filtering in ultrasonic strain-flow imaging.

Authors:  Christian Kargel; Gernot Höbenreich; Birgit Trummer; Michael F Insana
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2003-07       Impact factor: 2.725

Review 2.  Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.

Authors:  Brett Hall; Jennifer Dembinski; A Kate Sasser; Matus Studeny; Michael Andreeff; Frank Marini
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

Review 3.  Adipocytes: impact on tumor growth and potential sites for therapeutic intervention.

Authors:  Simona Hefetz-Sela; Philipp E Scherer
Journal:  Pharmacol Ther       Date:  2013-01-24       Impact factor: 12.310

4.  Priming cancer cells for drug resistance: role of the fibroblast niche.

Authors:  Wei Bin Fang; Min Yao; Nikki Cheng
Journal:  Front Biol (Beijing)       Date:  2014-02-01

Review 5.  Obesity and cancer: at the crossroads of cellular metabolism and proliferation.

Authors:  Robert W O'Rourke
Journal:  Surg Obes Relat Dis       Date:  2014-08-27       Impact factor: 4.734

6.  Mechanism of GPER promoting proliferation, migration and invasion of triple-negative breast cancer cells through CAF.

Authors:  Kaihua Yang; Yufeng Yao
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 7.  Lysyl oxidase: a potential target for cancer therapy.

Authors:  V M Berlin Grace; C Guruvayoorappan
Journal:  Inflammopharmacology       Date:  2010-11-24       Impact factor: 4.473

8.  Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

Authors:  Eugenio Maiorano; Meredith M Regan; Giuseppe Viale; Mauro G Mastropasqua; Marco Colleoni; Monica Castiglione-Gertsch; Karen N Price; Richard D Gelber; Aron Goldhirsch; Alan S Coates
Journal:  Breast Cancer Res Treat       Date:  2009-03-12       Impact factor: 4.872

9.  Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers.

Authors:  Min Yao; Elaine Yu; Vincent Staggs; Fang Fan; Nikki Cheng
Journal:  Mod Pathol       Date:  2016-04-29       Impact factor: 7.842

Review 10.  Liquid-based three-dimensional tumor models for cancer research and drug discovery.

Authors:  Stephanie L Ham; Ramila Joshi; Pradip S Thakuri; Hossein Tavana
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.